Jiangzhong Pharmaceutical Hits Day High with Strong 5.65% Intraday Surge

Jiangzhong Pharmaceutical Co., Ltd. has experienced a notable surge today, with the stock rising by 5.65% as of May 29, 2026. The stock reached an intraday high of CNY 25.14, reflecting a strong performance compared to the broader market, as the China Shanghai Composite index declined by 0.73% on the same day. Over the past week, Jiangzhong Pharmaceutical has shown a robust increase of 9.77%, while its one-month performance stands at 4.46%. Year-to-date, the stock has gained 8.11%, significantly outperforming the Shanghai Composite, which has only risen by 2.51%. However, over a longer horizon, the stock's performance has been mixed, with a 5-year increase of 120.9% contrasting with a 10-year decline of 15%. Key financial metrics indicate a return on equity of 22.90% and a price-to-book ratio of 3.32, suggesting an attractive valuation. The company also boasts a high dividend yield of 5.27%. Despite these positive indicators, the stock's long-term growth has been tempered by rising raw material costs and a flat performance in net sales.